Blood Test Shows Promise for Glioblastoma Diagnosis & Monitoring | Neuro-Oncology Advances
Glioblastoma (GBM), the most common and aggressive primary brain tumor in adults, presents a formidable challenge to clinicians due to its rapid progression and complex molecular characteristics. Accurate diagnosis and consistent monitoring are crucial for effective treatment, yet current methods often fall short. Now, a promising new approach utilizing blood-based protein analysis is offering a … Read more
